WPI 3 (Paliperidone Extended-Release 3 mg)
Pill with imprint WPI 3 is White, Round and has been identified as Paliperidone Extended-Release 3 mg. It is supplied by Actavis Pharma, Inc..
Paliperidone is used in the treatment of schizophrenia; schizoaffective disorder; bipolar disorder; depression; autism (and more), and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Paliperidone 3 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 3
Paliperidone Extended-Release
- Imprint:
- WPI 3
- Strength:
- 3 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Atypical antipsychotics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Actavis Pharma, Inc.
- National Drug Code (NDC):
- 00591-3693
More about paliperidone
- Paliperidone Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- 194 Reviews
- Drug class: atypical antipsychotics
Consumer resources
- Paliperidone
- Paliperidone injection
- Paliperidone Extended-Release Tablets
- Paliperidone (Advanced Reading)
- Paliperidone Intramuscular (Advanced Reading)
Other brands: Invega, Invega Sustenna, Invega Trinza
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
